Low-dose capsaicin (0.01 mM) nasal spray is equally effective as the current standard treatment for idiopathic rhinitis: A randomized, double-blind, placebo-controlled trial - 09/01/21

Laura Van Gerven, MD, PhD ^{a, b,} ∗

  These authors contributed equally to this work.

, Brecht Steelant, PhD ^b, ∗

  These authors contributed equally to this work.

, Leen Cools, MSc ^a, Ina Callebaut, PhD ^a, Wout Backaert, MD ^b, Jan de Hoon, MD, PhD ^c, Els Ampe, PhD ^c, Karel Talavera, PhD ^d, Peter W. Hellings, MD, PhD ^{a, b, e, f}

^a Department of Otorhinolaryngology, Head & Neck Surgery, University Hospitals Leuven, Leuven, Belgium 

^b Allergy and Clinical Immunology Research Unit, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium 

^c Center for Clinical Pharmacology, University Hospitals Leuven, Leuven, Belgium 

^d Laboratory for Ion Channel Research and TRP Research Platform Leuven (TRPLe), Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium 

^e Department of Otorhinolaryngology, Academic Medical Center Amsterdam, Amsterdam, The Netherlands 

^f Laboratory of Upper Airways Research, Department of Otorhinolaryngology, University of Ghent, Ghent, Belgium